BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  Job Trends

  Booming Visterra Outgrows Kendall Square Space, Heads to Suburbs

  Visterra has outgrown its headquarters and is moving to a site double the size in suburban Waltham, MA.

  February 6, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Biotech Bay

  2 Biotechs That Plunged More Than 20% Yesterday

  After yesterday’s big plunge in the stock market, and today with the Dow Jones Industrial Average dropping more than 500 points after opening, but mostly recovering, volatility appears to be the key word to describe the stock market.

  February 6, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  The Most Surprising Biotech Hub No One Really Knows About

  Cincinnati has had 90 percent growth in biotech startup investment since 2012.

  February 6, 2018

   · 

  1 min read
• 

  Business

  Effective Immediately: Genetic Technologies CEO Steps Down

  Mr Buccilli commenced with the Company in June 2014 as CFO and was appointed CEO in February 2015.

  February 6, 2018

   · 

  2 min read
• 

  Deals

  Two Drugmakers Compete for Sanofi’s $2.4B Generics Biz

  According to sources reported by Reuters, potential buyers have been winnowed down to two pharma companies, three private equity funds, and a consortium of buyers.

  February 6, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Meet the UK Biotech Developing a Vaccine for Every Type of Flu

  The company says the vaccine takes a novel approach.

  February 6, 2018

   · 

  1 min read
• 

  Business

  Why This Biotech CEO Injected Himself With a DIY Herpes Vaccine on Facebook Live

  The 28-year-old CEO of Ascendance Biomedical removed his trousers and injected himself at the BDYHAX conference in Texas.

  February 6, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Pharm Country

  Meet Precision Therapeutics, An Unloved Medtech With Significant Upside Potential

  A look at Precision Therapeutics’ upcoming catalysts.

  February 6, 2018

   · 

  1 min read
• Drug Development

  Endo Announces Initiation of Two Pivotal Phase III Clinical Trials of Collagenase Clostridium Histolyticum for the Treatment of Cellulite

  The multicenter, randomized, double-blind, placebo-controlled RELEASE studies will evaluate the safety and efficacy of CCH in reducing the appearance of cellulite.

  February 6, 2018

   · 

  6 min read
• Business

  LabCorp Announces Record 2017 Fourth Quarter and Full Year Results and Provides 2018 Guidance

  Net revenue for the quarter was $2.70 billion, an increase of 13.2% compared to $2.39 billion in the fourth quarter of 2016.

  February 6, 2018

   · 

  29 min read